[1]
F. Li, Z. Li, T. Wu, and Y. Wu, “The Analysis of Covid-19 Vaccine Influence on Pfizer Business”, BCPBM, vol. 34, pp. 776–783, Dec. 2022, doi: 10.54691/bcpbm.v34i.3096.